Try our beta test site
1 study found for:    NCT00817206
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily
Condition: Renal Failure
Interventions: Drug: LCP-Tacro;   Drug: Prograf

Study has passed its completion date and status has not been verified in more than two years.